Research Identity & Protocol Management

A centralized view of active clinical research protocols, ORCID-verified identity, and institutional record tracking — designed for precision, transparency, and research accountability.

Researcher Identity
ORCID-Verified Academic Profile
ORCID iD

This unique persistent identifier distinguishes this researcher from every other investigator and ensures that their contributions to science are reliably attributed — across institutions, name changes, and international boundaries.

ORCID (Open Researcher and Contributor ID) is the global standard for researcher identification, recognized by journals, funders, and academic institutions worldwide. Connecting publications, grants, and protocols to a single verified identity enables seamless, trustworthy scholarly communication.

Why ORCID Matters
Persistent Identity

Survives institutional changes, name updates, and career transitions

Global Recognition

Accepted by thousands of journals, funders, and research systems

Verified Attribution

Ensures credit for all scholarly and clinical contributions

Active Research Portfolio
Clinical Protocol Record Overview

The protocol record list provides a structured, real-time view of all active, in-progress, and released clinical trials under this researcher's purview. Each record is uniquely identified and mapped to ClinicalTrials.gov where applicable, ensuring full transparency and regulatory alignment.

Study Spotlight
Featured Active Protocols
HHI-INS-AUT-OBS-2025-001

Intranasal Insulin for Autism Spectrum Disorder — A study investigating insulin delivery in children and young adults aged 4–21 years (IN-INS-AUT). Currently In Progress.

MUSE-OVARY-001

Intra Ovarian Muse Cell Injection for Perimenopause — Symptom relief and ovarian function restoration (MUSE-OVARY). Status: Released. Linked to ClinicalTrials.gov.

HHI-ND-OBS-2025-001

Intensive Multimodal Neurorehabilitation — Targeting neuroplasticity in pediatric neurodevelopmental and chromosomal disorders (GEN-HOPE). ClinicalTrials.gov: NCT07493096.

Gene Therapy Research
Advanced Therapeutic Interventions
HHI-HIE-OBS-2025-001

Intranasal AAV9-PrPeB Gene Therapy in Cerebral Palsy (CP) and Hypoxic Ischemic Encephalopathy (HIE) — GEN-HGPE

ClinicalTrials.gov: NCT07264166

Status: Public

HHI-TBI-MUSE-001

Safety and Outcomes of MUSE Stem Cell Therapy in individuals with Traumatic Brain Injury (MUSE-TBI-OBS)

ClinicalTrials.gov: NCT07326059

Status: Public


Both studies represent cutting-edge interventional research in neurological recovery and regenerative medicine.

Regenerative Medicine
MUSE Stem Cell Research Program

The MUSE (Multilineage-differentiating Stress Enduring) cell research program spans two active protocols — targeting traumatic brain injury recovery and ovarian function restoration. These studies represent a significant frontier in regenerative and restorative medicine, exploring the body's own pluripotent stem cells as a therapeutic mechanism.

MUSE-TBI-OBS

Safety and outcomes monitoring for stem cell therapy post-traumatic brain injury

MUSE-OVARY

Intraovarian MUSE cell injection for perimenopause symptom relief and function restoration

Shared Goal

Harnessing endogenous pluripotent stem cells to restore tissue function without immune rejection

COVID-19 Research
HHI-IVIG-LC001 — Observational IVIG Study in Severe SARS-CoV-2
Study Overview

This observational protocol examines the use of Intravenous Immunoglobulin (IVIG) therapy in patients with severe acute respiratory syndrome caused by SARS-CoV-2. The study follows patients undergoing medical management to evaluate outcomes, safety signals, and immune response patterns.

ClinicalTrials.gov: NCT06992401 | Status: Public

Protocol Status at a Glance

Across all active records, this research portfolio reflects a diverse and rigorous commitment to clinical investigation — spanning gene therapy, stem cell biology, neurorehabilitation, and immunology.

6
Active Protocols

Unique research studies currently tracked and managed

5
ClinicalTrials.gov IDs

Federally registered trials with public visibility

4
Therapeutic Areas

Neurology, regenerative medicine, women's health, and immunology

1
ORCID iD

Verified persistent researcher identity across all contributions

Record Management
Institutional Protocol Tracking System

The record management interface — as visible in the protocol record list — provides administrators and investigators with a structured, searchable view of all registered studies. Key capabilities include:

Unique Protocol IDs

Each study is assigned a structured institutional identifier for unambiguous tracking across departments and regulatory bodies.

Problem Resolution Flags

The system surfaces data quality issues — such as incomplete entries or unreleased records — enabling proactive resolution before submission.

ClinicalTrials.gov Linkage

Direct mapping between institutional records and federal registry IDs ensures regulatory compliance and public transparency.

Record Status Tracking

Statuses such as In Progress, Released, and Public provide real-time visibility into each protocol's lifecycle stage.

Verified Identity
Connect With This Researcher

All publications, grants, protocols, and scholarly outputs associated with this investigator are linked through a single, verified ORCID identity. Whether you are a collaborator, journal editor, funding agency, or research administrator, the ORCID profile provides the authoritative source for this researcher's academic record.

orcid.org

ORCID

ORCID Profile: 0000-0001-8213-6953